Pharmacoepidemiology of Treatment-Resistant Schizophrenia: Structure and Frequency of Adverse Drug Reactions in Real-World Clinical Practice

INTRODUCTION. Treatment-resistant schizophrenia (TRS) represents one of the most challenging clinical problems in psychiatry. Clozapine remains the only antipsychotic with proven efficacy for TRS; however, in real-world clinical practice, patients frequently receive combinations of antipsychotic med...

ver descrição completa

Detalhes bibliográficos

Principais autores:	D. N. Sosin, E. A. Mozol, D. A. Golovina, A. V. Oskin, A. T. Tepaev, A. G. Kirova, L. A. Burygina, S. N. Mosolov, D. A. Sychev
Formato:	Artigo
Idioma:	Russo
Publicado em:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-03-01
coleção:	Безопасность и риск фармакотерапии
Assuntos:	фармакоэпидемиология клозапин антипсихотики терапевтическая резистентность при шизофрении метод глобальных триггеров фармаконадзор безопасность лекарственных средств эффективность фармакотерапии ретроспективное исследование
Acesso em linha:	https://www.risksafety.ru/jour/article/view/556
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!